why choose us

First received: August 10, 2023

Clinical Trial: Anthrax AV7909 Boost Evaluation Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anthrax

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blinded, Multicenter Study in Healthy Adults to Evaluate Safety and Immunogenicity of AV7909 Administered at Two Dose Levels on Two Vaccination Schedules, Including a Primary Seri

Brief Summary: This randomized, phase 2, double-blinded, multicenter study is designed to assess the safety and immune response kinetics of AV7909 administered on 2 primary series vaccination schedules followed by 6- and 12-month boosters.

Read more